Praxis precision medicines stock.

52 Week Low Stock Chart Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Praxis Precision Medicines, …Certain Common Stock of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 14-SEP-2023. Sep. 13: CI HC Wainwright Adjusts Price Target on Praxis Precision Medicines to $7 From $15, Keeps Buy Rating Aug. 10: MT Earnings Flash (PRAX) PRAXIS PRECISION MEDICINES Reports Q2 Revenue …Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal ...Stock analysis for Praxis Precision Medicines Inc (PRAX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.As of December 31, 2022, Praxis had 49.4 million shares of common stock outstanding. About Praxis Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance.

On June 2, 2023, Praxis Precision Medicines Inc (PRAX) experienced a surge in stock performance following positive analyst forecasts. According to data from CNN Money, the four analysts offering 12-month price forecasts for PRAX had a median target of 9.50, with a high estimate of 18.00 and a low estimate of 2.00.Get the latest Praxis Precision Medicines, Inc. (PRAX) stock quote, history, news and other vital information to help you with your stock trading and investing. See the current price, performance outlook, earnings date, dividend yield, market cap and more.

Certain Stock Options of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 14-SEP-2023. Sep. 13: CI Certain Common Stock of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 14-SEP-2023. Sep. 13: CIAs of March 31, 2023, Praxis had 58.0 million shares of common stock outstanding. About Praxis Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance.

See Praxis Precision Medicines, Inc. (PRAX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Praxis Precision Medicines Trading Up 4.4 %. Shares of Praxis Precision Medicines stock opened at $1.18 on Friday. The business’s fifty day simple moving average is $1.25 and its 200 day simple moving average is $1.18. The firm has a market capitalization of $151.69 million, a P/E ratio of -0.52 and a beta of 2.79.BOSTON, April 19, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will deliver …Certain Common Stock of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 14-SEP-2023. Sep. 13: CI HC Wainwright Adjusts Price Target on Praxis Precision Medicines to $7 From $15, Keeps Buy Rating Aug. 10: MT Earnings Flash (PRAX) PRAXIS PRECISION MEDICINES Reports Q2 Revenue …

Dec 1, 2023 · Which Praxis Precision Medicines insiders have been buying company stock? The following insiders have purchased PRAX shares in the last 24 months: Alex Nemiroff ($12,225.00), Dean J Mitchell ($87,227.70), Jill Desimone ($25,357.50), Lauren Mastrocola ($5,790.00), Marcio Souza ($90,635.10), and Timothy Edwin Kelly ($17,582.40).

Find the latest Praxis Precision Medicines, Inc. (PRAX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest Praxis Precision Medicines Inc (Prax) discussion and analysis from iHub's community of investors.... Legal Name Praxis Precision Medicines, Inc. Stock Symbol NASDAQ:PRAX; Company Type For Profit. Phone Number (617)949-2220. Praxis Precision Medicines ...Nov 28, 2023 · What was the 52-week high for Praxis Precision Medicines stock? The high in the last 52 weeks of Praxis Precision Medicines stock was 5.25. According to the current price, Praxis Precision ... Praxis Precision Medicines Stock Down 3.5 %. Shares of PRAX opened at $17.56 on Monday. The company has a market cap of $150.49 million, a PE ratio of -0.52 and a beta of 2.78. The business has a fifty day moving average of $18.35 and a 200 day moving average of $17.80. Praxis Precision Medicines has a 52-week low of $11.85 and a 52-week high ...Praxis reported net loss of $44.7 million for the three months ended September 30, 2021, including $6.5 million of stock-based compensation expense, compared to a net loss of $16.2 million for the ...Praxis Precision Medicines' cash burn of US$100m is about 15% of its US$661m market capitalisation. As a result, we'd venture that the company could raise more cash for growth without much trouble ...

Certain Common Stock of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 14-SEP-2023. Sep. 13: CI HC Wainwright Adjusts Price Target on Praxis Precision Medicines to $7 From $15, Keeps Buy Rating Aug. 10: MT Earnings Flash (PRAX) PRAXIS PRECISION MEDICINES Reports Q2 Revenue …Track Praxis Precision Medicines Inc (PRAX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsStock analysis for Praxis Precision Medicines Inc (PRAX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Sep 7, 2022 · Praxis undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Investor Contact: Alex Kane Praxis Precision Medicines [email protected] 617-300-8481 Media Contact: Ian Stone Canale Communications [email protected] 619-849-5388 Praxis undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Investor Contact: Alex Kane Praxis Precision Medicines [email protected] 617-300-8481 Media Contact: Ian Stone Canale Communications …UNAUDITED SELECTED FINANCIAL DATA Reverse Stock Split On November 28, 2023, at 5:00 p.m., Eastern Time, Praxis Precision Medicines, Inc. effected a 1-for-15... 0be.QjvltC2QB-4Er1J5HgwN7Cv_FyRCoR-vWQQhzjfpPYQ.M26rzF6hQK1852AQTEpJp0eLRHEn0S_FGnwSpUa6Bcx6cIHjAOBA1k3HCw0.00%. $42.62. PRAX | Complete Praxis Precision Medicines Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Discover historical prices for PRAX stock on Yahoo Finance. View daily, weekly or monthly format back to when Praxis Precision Medicines, Inc. stock was issued.

May 7, 2023 · However, When quite a few insiders buy shares, as it happened in Praxis Precision Medicines, Inc.'s (NASDAQ:PRAX) ... insiders own US$671k worth of Praxis Precision Medicines stock, about 1.1% of ... Check out our latest analysis for Praxis Precision Medicines . When Might Praxis Precision Medicines Run Out Of Money? A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. In June 2023, Praxis Precision Medicines had US$124m in cash, and was …Praxis Precision Medicines, Inc. (PRAX) will effect a one-for-fifteen (1-15) reverse split of its Common Stock. The reverse stock split will become effective on …Find real-time PRAX - Praxis Precision Medicines Inc stock quotes, company profile, ... Praxis Precision Medicines Inc (NASDAQ:PRAX) 18.00. Delayed Data. As of Nov 30 +0.77 / +4.42%. In addition, Praxis Precision Medicines, Inc. has a VGM Score of D (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal ...Feb 6, 2023 · Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalances. The Praxis Precision Medicines, Inc. stock price fell by -9.09% on the last day (Tuesday, 28th Nov 2023) from $1.21 to $1.10. During the last trading day the stock fluctuated 11.21% from a day low at $1.07 to a day high of $1.19. The price has risen in 7 of the last 10 days and is up by 26.44% over the past 2 weeks.

Praxis undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Investor Contact: Praxis Precision Medicines [email protected] 857-702-9452 Media Contact: Ian Stone Evoke Canale [email protected] 619-849-5388

A company's cash runway is calculated by dividing its cash hoard by its cash burn. As at September 2023, Praxis Precision Medicines had cash of US$101m and no debt. Looking at the last year, the company burnt through US$116m. So it had a cash runway of approximately 10 months from September 2023. To be frank, this kind of short …

Find the latest Praxis Precision Medicines, Inc. (PRAX) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Praxis Precision Medicines, Inc. (PRAX) stock quote, history, news and other vital information to help you with your stock trading and ...CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance, today announced that it has …Praxis Precision Medicines Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PRAX updated stock price target summary.The average twelve-month price prediction for Praxis Precision Medicines is $6.33 with a high price target of $10.00 and a low price target of $2.00. Learn more on PRAX's analyst rating history.Praxis undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Investor Contact: Praxis Precision Medicines [email protected] 857-702-9452 Media Contact: Ian Stone Evoke Canale [email protected] 619-849-5388See the latest Praxis Precision Medicines Inc Ordinary Shares stock price (NASDAQ:PRAX), related news, valuation, dividends and more to help you make your investing decisions.Valuation metrics show that Praxis Precision Medicines, Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects ...Complete Praxis Precision Medicines Inc. stock information by Barron's. View real-time PRAX stock price and news, along with industry-best analysis. Praxis Precision Medicines Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PRAX updated stock price target summary.

Mar 3, 2023 · Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalances. Certain Common Stock of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 14-SEP-2023. Sep. 13: CI HC Wainwright Adjusts Price Target on Praxis Precision Medicines to $7 From $15, Keeps Buy Rating Aug. 10: MT Earnings Flash (PRAX) PRAXIS PRECISION MEDICINES Reports Q2 Revenue …Praxis Precision Medicines Announces Proposed Public Offering of Common Stock. CAMBRIDGE, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage ...Instagram:https://instagram. stock ticker dddabb share priceregulated brokers forexupwork net worth Praxis Precision Medicines stock dips on pricing $59.1M securities offering SA News Fri, Jun. 16. Praxis Precision Medicines proposes stock offering, shares slip SA News Thu, Jun. 15.Praxis Precision Medicines Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PRAX updated stock price target summary. best lithium ion battery stockses mini Praxis Precision Medicines stock dips on pricing $59.1M securities offering From Seeking Alpha Jun 16, 2023 Praxis Precision Medicines (PRAX) shares fell 6.15% premarket on Friday after the ... us 5 year treasury bond yield The low in the last 52 weeks of Praxis Precision Medicines stock was 0.79. According to the current price, Praxis Precision Medicines is 141.77% away from the 52-week low. What was the 52-week ...Nov 28, 2023 · Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal ... Nov 21, 2023 · A high-level overview of Praxis Precision Medicines, Inc. (PRAX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.